Dowless, M. (2018). Abemaciclib Is Active in Preclinical Models of Ewing Sarcoma via Multipronged Regulation of Cell Cycle, DNA Methylation, and Interferon Pathway Signaling. The American Association for Cancer Research (AACR).
Chicago Style (17th ed.) CitationDowless, M. Abemaciclib Is Active in Preclinical Models of Ewing Sarcoma via Multipronged Regulation of Cell Cycle, DNA Methylation, and Interferon Pathway Signaling. The American Association for Cancer Research (AACR), 2018.
MLA (9th ed.) CitationDowless, M. Abemaciclib Is Active in Preclinical Models of Ewing Sarcoma via Multipronged Regulation of Cell Cycle, DNA Methylation, and Interferon Pathway Signaling. The American Association for Cancer Research (AACR), 2018.
Warning: These citations may not always be 100% accurate.